« Back to Record
Citation APA

Loi, S., Michiels, S., Salgado, R., Sirtaine, N., Jose, V., Fumagalli, D., Kellokumpu-Lehtinen, P.-L., Bono, P., Kataja, V., Desmedt, C., Piccart-Gebhart, M., Loibl, S., Denkert, C., Smyth, M. J., Joensuu, H., & Sotiriou, C. (2014). Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Annals of oncology. doi:10.1093/annonc/mdu112


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/158707

Loi, S., Michiels, S., Salgado, R., Sirtaine, N., Jose, V., Fumagalli, D., Kellokumpu-Lehtinen, P.-L., Bono, P., Kataja, V., Desmedt, C., Piccart-Gebhart, M., Loibl, S., Denkert, C., Smyth, M. J., Joensuu, H., & Sotiriou, C. (2014). Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Annals of oncology. doi:10.1093/annonc/mdu112